Categories
FEATURED Technology

Apple Inc. (NASDAQ:AAPL) announced senior executive’s departure

Apple Inc. (NASDAQ:AAPL) announced the senior executive’s departure Thursday, saying he will leave later this year to form an independent design company that will count Apple as a client. Ive has been an integral part of the company’s device designs, from 1998’s iMac to the company’s new headquarters. Jony Ive, the industrial designer who helped shape the look of Apple’s most iconic devices from the iPod to the iPhone, is stepping down later this year.

Apple Inc. (NASDAQ:AAPL), a Consumer Goods sector firm, traded 20.33 Million shares in last trading session with closing price of $199.74 per share. Company gross margin stands at 38.10% whereas its return on investment (ROI) is 26.60%. Stock value has moved between $141.66 – 232.26 in last one year. Analyst’s mean target price for Apple Inc. (NASDAQ:AAPL) is $210.89 while analysts mean recommendation is 2.20. AAPL EPS growth this year is 32.60%. 

On last trading day, Marathon Petroleum Corporation (NYSE:MPC) shares closed at $54.37 per share. MPC market capitalization is 36591.01 with beta of 1.57. Analyst’s mean target price for Marathon Petroleum Corporation (NYSE:MPC) is $82.27 whereas analysts mean recommendation is 1.60. Its weekly performance is 4.66% while year to date (YTD) performance is -7.86%. 

In last session Thermo Fisher Scientific Inc. (NYSE:TMO) traded 847669 shares and was closed at $293.77. Analyst’s mean target price for TMO is $296.63 while analysts mean recommendation is 1.70. Company is -1.54% away from its 52 week high and is moving 44.84% ahead of its 52 week low. TMO Gross Margin is 44.60% and its return on assets is 5.70%. Thermo Fisher Scientific Inc. (NYSE:TMO) quarterly performance is 8.68% while its price to sale ratio is 4.77. 

BioPharmX Corporation (NYSE:BPMX), a Healthcare sector firm, traded 2.59 Million shares on last trading day with closing price of $0.61 per share. Stock value has moved between $0.6 – 6.78 in last one year. Analyst’s mean target price for BioPharmX Corporation (NYSE:BPMX) is $5.63. BPMX EPS growth this year is 14.50%. 

Leave a Reply